Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Molecular Relatives: Prodrugs

Posted on May 19th, 2016 by in Pharma R&D

I’m an avid sailor, and on our boat we have an amazing device known as a water-maker. It is probably one of the most useful pieces of equipment on board for long cruises, as it takes in sea water, and, through a process of reverse osmosis, provides potable drinking water. Continue reading “Molecular Relatives: Prodrugs” »

How Text-Mining Positively Impacts Early Stage Discovery

Posted on March 29th, 2016 by in Pharma R&D

Colleagues, as most of you know, text mining is the process to derive high quality structured information from unstructured text, Continue reading “How Text-Mining Positively Impacts Early Stage Discovery” »

Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?

Posted on January 12th, 2016 by in Pharma R&D

It’s the turn of the year and if you’re like me, you’ve been immersed in reading all of the accompanying look back and look ahead articles and reports. 2015 was, indeed, a notable year — from the Martin Shkreli fiasco to the proposed Pfizer and Allergan merger — the industry was rocked. Continue reading “Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?” »

Reaxys: Then & Now

Posted on October 30th, 2015 by in Chemistry

Reaxys, an online chemistry research solution from Reed Elsevier Properties SA, improves R&D productivity by delivering experimental facts on chemical structures, properties, reactions and procedures. It’s been around since 2009, but what came before it directly shaped what Reaxys was, what it is today and what it will be in the future. Discover the history of Reaxys. Continue reading “Reaxys: Then & Now” »